Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1969 Dec;23(4):875–890.

Specific activities of uridine phosphorylase and uridine kinase in Ehrlich ascites carcinoma cells and 6-azauracil- and 6-azauridine-treated sublines in successive transplant generations.

D G Blair, A D Hall
PMCID: PMC2008489  PMID: 5395610

Full text

PDF
875

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHAUDHURI N. K., MONTAG B. J., HEIDELBERGER C. Studies on fluorinated pyrimidines. III. The metabolism of 5-fluorouracil-2-C14 and 5-fluoroorotic-2-C14 acid in vivo. Cancer Res. 1958 Apr;18(3):318–328. [PubMed] [Google Scholar]
  2. HANDSCHUMACHER R. E. Orotidylic acid decarboxylase: inhibition studies with azauridine 5'-phosphate. J Biol Chem. 1960 Oct;235:2917–2919. [PubMed] [Google Scholar]
  3. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  4. PASTERNAK C. A., FISCHER G. A., HANDSCHUMACHER R. E. Alterations in pyrimidine metabolism in L5178Y leukemia cells resistant to 6-azauridine. Cancer Res. 1961 Jan;21:110–117. [PubMed] [Google Scholar]
  5. PATERSON A. R. The development of resistance to 6-mercaptopurine in a subline of the Ehrlich ascites carcinoma. Can J Biochem Physiol. 1960 Oct;38:1117–1127. [PubMed] [Google Scholar]
  6. PHILLIPS H. J., TERRYBERRY J. E. Counting actively metabolizing tissue cultured cells. Exp Cell Res. 1957 Oct;13(2):341–347. doi: 10.1016/0014-4827(57)90013-7. [DOI] [PubMed] [Google Scholar]
  7. PONTIS H., DEGERSTEDT G., REICHARD P. Uridine and deoxyuridine phosphorylases from Ehrlich ascites tumor. Biochim Biophys Acta. 1961 Jul 22;51:138–147. doi: 10.1016/0006-3002(61)91024-1. [DOI] [PubMed] [Google Scholar]
  8. Pinsky L., Krooth R. S. Studies on the control of pyrimidine biosynthesis in human diploid cell strains, I. Effect of 6-azauridine on cellular phenotype. Proc Natl Acad Sci U S A. 1967 Apr;57(4):925–932. doi: 10.1073/pnas.57.4.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. REICHARD P., SKOLD O. Enzymes of uracil metabolism in the Ehrlich ascites tumour and mammalian liver. Biochim Biophys Acta. 1958 May;28(2):376–385. doi: 10.1016/0006-3002(58)90485-2. [DOI] [PubMed] [Google Scholar]
  10. REICHARD P., SKOLD O., KLEIN G. Possible enzymic mechanism for the development of resistance against fluorouracil in ascites tumours. Nature. 1959 Apr 4;183(4666):939–941. doi: 10.1038/183939a0. [DOI] [PubMed] [Google Scholar]
  11. REICHARD P., SKOLD O., KLEIN G., REVESZ L., MAGNUSSON P. H. Studies on resistance against 5-fluorouracil. I. Enzymes of the uracil pathway during development of resistance. Cancer Res. 1962 Feb;22:235–243. [PubMed] [Google Scholar]
  12. Rainnie D. J., Blair D. G. Uridine phosphorylase and uridine kinase activities of the Ehrlich ascites carcinoma. Can J Biochem. 1969 Apr;47(4):429–432. doi: 10.1139/o69-066. [DOI] [PubMed] [Google Scholar]
  13. SKOLD O., MAGNUSSON P. H., REVESZ L. Studies on resistance against 5-fluorouracil. III. Selective value of resistant, uridine kinase-deficient tumor cells. Cancer Res. 1962 Nov;22:1226–1229. [PubMed] [Google Scholar]
  14. SORM F., KEILOVA H. The anti-tumour activity of 6-azauracil riboside. Experientia. 1958 Jun 15;14(6):215–215. doi: 10.1007/BF02159094. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES